ATE376425T1 - Verfahren zur behandlung bestimmter augenkrankheiten - Google Patents

Verfahren zur behandlung bestimmter augenkrankheiten

Info

Publication number
ATE376425T1
ATE376425T1 AT01957398T AT01957398T ATE376425T1 AT E376425 T1 ATE376425 T1 AT E376425T1 AT 01957398 T AT01957398 T AT 01957398T AT 01957398 T AT01957398 T AT 01957398T AT E376425 T1 ATE376425 T1 AT E376425T1
Authority
AT
Austria
Prior art keywords
eye
eye diseases
treating certain
human patient
visual acuity
Prior art date
Application number
AT01957398T
Other languages
English (en)
Inventor
Gerard Nolan
Original Assignee
Nolan Gerard M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nolan Gerard M filed Critical Nolan Gerard M
Application granted granted Critical
Publication of ATE376425T1 publication Critical patent/ATE376425T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01957398T 2001-01-31 2001-08-03 Verfahren zur behandlung bestimmter augenkrankheiten ATE376425T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/773,878 US6605640B2 (en) 2001-01-31 2001-01-31 Method of treating certain eye diseases

Publications (1)

Publication Number Publication Date
ATE376425T1 true ATE376425T1 (de) 2007-11-15

Family

ID=25099599

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01957398T ATE376425T1 (de) 2001-01-31 2001-08-03 Verfahren zur behandlung bestimmter augenkrankheiten

Country Status (7)

Country Link
US (1) US6605640B2 (de)
EP (1) EP1365771B9 (de)
JP (1) JP2004530645A (de)
AT (1) ATE376425T1 (de)
CA (1) CA2436397A1 (de)
DE (2) DE60131100T4 (de)
WO (1) WO2002060451A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2292239A3 (de) * 2003-04-18 2011-03-30 Advanced Medicine Research Institute Mittel zur Behandlung von Krankheiten zur Aufbringung auf das Auge
CA2522043A1 (en) * 2003-04-25 2004-11-11 Gerard M. Nolan Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage
JP2005154320A (ja) * 2003-11-25 2005-06-16 Ss Pharmaceut Co Ltd 眼疾患治療薬
MX2019001877A (es) 2016-08-19 2019-09-13 Orasis Pharmaceuticals Ltd Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas.
CA3070556A1 (en) 2017-07-20 2019-01-24 Alan Laboratories, Inc. Compositions and methods for treatment of myopia
KR20210046693A (ko) * 2018-08-08 2021-04-28 세인다 파마슈티컬 광저우 코포레이션 노안 치료용 조성물 및 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288735A (en) 1989-05-02 1994-02-22 Trager Seymour F Treatment of glaucoma
CA2323749A1 (en) 1998-03-06 1999-09-10 William E. Sponsel Composition and method for treating macular disorders
US6273092B1 (en) 2000-09-22 2001-08-14 Gerard M. Nolan Methods for treating various eye disorders

Also Published As

Publication number Publication date
DE60131100T4 (de) 2009-07-09
EP1365771A4 (de) 2005-12-21
CA2436397A1 (en) 2002-08-08
DE60131100T2 (de) 2008-07-31
EP1365771B1 (de) 2007-10-24
EP1365771B9 (de) 2008-11-12
WO2002060451A1 (en) 2002-08-08
EP1365771A1 (de) 2003-12-03
US20020103167A1 (en) 2002-08-01
JP2004530645A (ja) 2004-10-07
US6605640B2 (en) 2003-08-12
DE60131100D1 (de) 2007-12-06

Similar Documents

Publication Publication Date Title
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DE60227658D1 (de) Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren
DE60239612D1 (de) Monodisperse mischungen und verfahren zur behandlung von diabetes
MX2009005279A (es) Derivados de n-(metil)-1h-pirazol-3-amina, n-(metil)-piridin-2-ami na y n-(metil)-tiazol-2-amina para el tratamiento de enfermedades asociadas con proteinas amiloides o tipo amiloide, tal como por ejemplo alzheimer.
SE9803710D0 (sv) Use of certain drugs for treating nerve root injury
DE60216830D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
ATE330631T1 (de) Antikörperfragmente zur lokalen behandlung von augenerkrankungen
ATE491444T1 (de) Verfahren zur behandlung von schmerzen durch verabreichung eines nervenwachstumsfaktor- antagonisten und eines nsaid und diese enthaltende zusammensetzung
ATE522229T1 (de) Anti-ngf-antikörper zur behandlung verschiedener erkrankungen
DE69833971D1 (de) Verfahren zur behandlung von alzheimerschen krankheit
EP0792156A4 (de) Verfahren zur vorbeugung oder behandlung von vaskulären hämorragien und der alzheimerischen krankheit
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
ATE355852T1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
WO2004071431A3 (en) Method and composition for treating neurodegenerative disorders
NO20055937L (no) Anvendels av triglyseridoljer inneholdende gamma-linolensyrerester og linolsyrerester for behandlingen av nevrodegenerativ sydkom
ATE331527T1 (de) Verfahren zur behandlung von brustdrüsenerkrankungen
ATE435026T1 (de) Verfahren zur prävention und behandlung von diabetes mit neurturin
DE602004002394D1 (de) (3-ä3-'(2,4-BIS-TRIFLUORMETHYL-BENZYL)-(5-ETHYL-PYRIMIDIN-2-YL)-AMINOÜ-PROPOXYü-PHENYL)-ESSIGSÄURE UND VERWANDTE VERBINDUNGEN ALS MODULATOREN VON PPARS UND VERFAHREN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN
ATE375141T1 (de) Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
DE69534620D1 (de) Verfahren zur behandlung von augenerkrankungen
DE60131100D1 (de) Verfahren zur behandlung bestimmter augenkrankheiten
ATE251911T1 (de) Löslische hla-g enthaltende zusammensetsungen zur behandlung entzündlichen hautkrankheiten
ATE285773T1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
ATE382347T1 (de) Pharmazeutische zusammensetzung zur verwendung bei der behandlung von malignen erkrankungen, umfassend eine kombination aus bisphosphonaten, einem cox-2 inhibitor und einem taxol
DE60306503D1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties